The Fidelity MSCI Health Care Index ETF (FHLC) has seen insider buying in 19.6% of its weighted holdings over the past six months, signaling internal confidence within the sector. Key examples include Elevance Health Inc (ELV), a 1.24% holding, where the CEO and a director purchased over $2.8 million in shares, and Masimo Corp. (MASI), a 0.11% holding, which recorded over $460,000 in director purchases. This widespread insider activity suggests a positive outlook from company leadership for these healthcare components.
A significant bullish signal is emerging from the Fidelity MSCI Health Care Index ETF (FHLC), where 19.6% of its weighted underlying holdings have experienced insider buying within the last six months. This broad-based internal confidence is exemplified by two key components. At Elevance Health (ELV), which comprises 1.24% of the ETF, President and CEO Gail Boudreaux executed a high-conviction purchase of 8,500 shares valued at approximately $2.44 million at a price of $286.94. With ELV's last trade at $319.69, this C-suite investment is already showing a substantial unrealized gain. A second holding, Masimo Corp. (MASI), representing 0.11% of the ETF, also saw two directors purchase shares. Notably, their purchase prices of $145.98 and $152.80 are above the stock's last trade of $142.94, suggesting that while insiders perceived value at those levels, the market has since moved lower. The combination of widespread insider buying across the ETF and significant, high-level purchases in individual names points to positive sentiment from corporate leaders regarding their firms' prospects.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment
